Venture Capital Investors

SV Health Investors

SV Health Investors is a venture capital fund that assists tech entrepreneurs.

Venture Investor Overview

Venture Investor
SV Health Investors
Status
Active
Investor Type
Venture Capital
Activity Level
214 transactions
Funds Raised
At least $1.4 billion
Industry Focus
Biopharmaceutical
Healthcare IT
Healthcare Services
Life Sciences
Medical Devices & Instruments

Contact Information

Contact
Eugene Hill
Title
Managing Partner
Mailing Address
1 Boston Pl. 201 Washington St. 3900
Boston, MA 02108
USA
Phone
(617) 367-8100
Website
www.svhealthinvestors.com
Email Address
Not Recorded

Background Information

Overview
SV Health Investors is a global leader in healthcare investing. Talented investment professionals and healthcare industry veterans drive our success. Investment sectors range from biotechnology & pharmaceuticals to Medical Devices & Instruments & instruments, to healthcare information technology and services.
Profile
SV Health Investors LinkedIn Company Profile
Social Media
SV Health Investors Company Twitter Account
Company News
SV Health Investors News
Facebook
SV Health Investors on Facebook
YouTube
SV Health Investors on YouTube
Last Transaction
11/14/2024

Transaction History

Our records indicate that SV Health Investors invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Company
Date
Amount
TRexBio
11/14/2024
$84,000,000
Enara Bio
10/3/2024
$32,500,000
SpectraWAVE
9/11/2024
$50,000,000
CSA Medical
9/9/2024
$53,000,000
Spineology
8/6/2024
$25,000,000
Montara Therapeutics
7/30/2024
$8,000,000
Brixton Biosciences
5/14/2024
$33,000,000
MIACH Orthopaedics
4/3/2024
$20,000,000
BioAge Labs
2/13/2024
$170,000,000
EyeBio
11/14/2023
$65,000,000
Sitryx Therapeutics
9/27/2023
$39,000,000
Nimbus Therapeutics
9/6/2023
$210,000,000
Therini Bio
4/27/2023
$36,000,000
Health Payment Systems
1/26/2023
$25,000,000
Pulmocide
12/6/2022
$52,000,000
Nimbus Therapeutics
9/12/2022
$125,000,000
Nanopath
8/9/2022
$10,000,000
Ria Health
6/29/2022
$18,000,000
EyeBiotech
3/11/2022
$65,000,000
Quell Therapeutics
11/30/2021
$156,000,000
TRexBio
6/23/2021
$59,000,000
Therini Bio
5/11/2021
$17,000,000
Xilio Therapeutics
2/25/2021
$95,000,000
Catamaran Bio
11/24/2020
$42,000,000
Evidation Health
7/2/2020
$45,000,000
Xilio Therapeutics
3/3/2020
$100,500,000
EBT Medial
12/5/2019
$10,000,000
Healthify
11/5/2019
$16,000,000
Clarify Medical
10/24/2019
$18,000,000
AeroCare
10/22/2019
Unknown
Bardy Diagnostics
4/17/2019
$35,500,000
Rheostat Therapeutics
11/27/2018
$23,000,000
Ribometrix
11/14/2018
$30,000,000
CSA Medical
10/10/2018
$23,000,000
Endotronix
9/15/2018
$45,000,000
Evidation Health
8/2/2018
$30,000,000
Sutro Biopharma
7/30/2018
$85,400,000
Avrobio
2/2/2018
$60,000,000
Pionyr Immunotherapeutics
12/14/2017
$62,000,000
Ribometrix
11/1/2017
$7,500,000
PanOptica
10/10/2017
$11,000,000
Arsanis
4/27/2017
$45,500,000
Pulmocide
3/22/2017
$30,000,000
Pionyr Immunotherapeutics
1/5/2017
$8,000,000
SUN Behavioral Health
11/17/2016
$34,000,000
Bardy Diagnostics
9/30/2016
$23,614,000
Precision Immune
9/30/2016
$8,000,000
Aligned TeleHealth
8/9/2016
$12,000,000
Avrobio
8/3/2016
$25,000,000
Endotronix
7/15/2016
$32,000,000
Jet Health
4/27/2016
$16,650,000
Deciphera Pharmaceuticals
1/5/2016
$15,000,000
Kesios Therapeutics
12/3/2015
$28,420,000
ReShape Medical
8/26/2015
$38,000,000
Avitide
8/6/2015
Unknown
KalVista Pharmaceuticals
7/23/2015
$33,000,000
EBR Systems
4/8/2015
$20,000,000
Catabasis Pharmaceuticals
3/31/2015
$12,414,000
CardioKinetix
12/9/2014
$50,000,000
Direct Flow Medical
12/3/2014
$32,000,000
Ximedica
11/6/2014
Unknown
AcuFocus
9/4/2014
$21,000,000
Spinal Kinetics
6/4/2014
$34,000,000
PanOptica
4/15/2014
$45,000,000
Thesan Pharmaceuticals
2/25/2014
$49,000,000
AqueSys
1/16/2014
$43,600,000
Cibiem
12/31/2013
$5,000,000
AlloCure
12/31/2013
$10,000,000
CSA Medical
12/23/2013
$16,000,000
Sutro Biopharma
12/11/2013
$26,000,000
Catabasis Pharmaceuticals
11/14/2013
$32,400,000
Arsanis
9/30/2013
$12,999,900
Arsanis
9/3/2013
$20,000,000
Cibiem
3/31/2013
$5,000,000
Rempex Pharmaceuticals
3/31/2013
$20,000,000
Coridea
3/31/2013
$1,000,000
ReShape Medical
3/31/2013
$6,915,000
NKT Therapeutics
3/31/2013
$4,000,000
Catabasis Pharmaceuticals
3/31/2013
$8,750,000
Avitide
3/16/2013
$1,449,999
Ocular Therapeutix
1/28/2013
$23,800,000
Good Start Genetics
12/31/2012
$4,000,000
Entellus Medical
12/31/2012
$10,000,000
Health Essentials
10/25/2012
Unknown
ReShape Medical
10/22/2012
$15,822,657
Cibiem
10/18/2012
$10,000,000
Catabasis Pharmaceuticals
9/30/2012
$8,800,000
Cyterix Pharmaceuticals
9/30/2012
$7,290,000
NKT Therapeutics
9/30/2012
$2,000,000
Sutro Biopharma
5/8/2012
$16,500,000
Good Start Genetics
4/2/2012
$14,000,000
AlloCure
4/2/2012
$25,000,000
PanOptica
3/31/2012
$6,047,000
Coridea
12/31/2011
$2,000,000
CSA Medical
12/15/2011
$20,500,000
Catabasis Pharmaceuticals
12/13/2011
$8,000,000
AcuFocus
11/30/2011
$65,000,000
Rempex Pharmaceuticals
11/9/2011
$67,500,000
Imagen Biotech
10/19/2011
$40,000,000
Altura Medical
9/30/2011
$3,750,000
CardioKinetix
9/21/2011
$44,000,000
PINT
8/29/2011
$15,000,000
Entellus Medical
8/18/2011
$35,000,000
Halscion
6/30/2011
$3,499,900
US Renal Care
6/30/2011
$295,000
Cyterix Pharmaceuticals
6/8/2011
$9,200,000
Arsanis
2/8/2011
$10,000,000
Ocular Therapeutix
2/2/2011
$14,000,000
PanOptica
1/4/2011
$30,000,000
Sutro Biopharma
11/17/2010
$36,500,000
Good Start Genetics
9/10/2010
$18,000,000
AqueSys
6/29/2010
$35,000,000
Altura Medical
6/2/2010
$20,000,000
Logical Therapeutics
5/27/2010
$16,900,000
Link Medicine
5/4/2010
$5,000,000
Catabasis Pharmaceuticals
4/21/2010
$39,600,000
Juvaris BioTherapeutics
1/27/2010
$25,000,000
valenTx
1/5/2010
$22,000,000
EBR Systems
12/31/2009
$15,000,000
Neurotech Pharmaceuticals
12/31/2009
$5,700,100
AlloCure
12/31/2009
$6,000,000
Halscion
12/31/2009
$6,000,000
Aiko Biotechnology
12/8/2009
$1,200,000
Entellus Medical
11/17/2009
$30,000,000
Lux Biosciences
10/19/2009
$50,000,000
TransEnterix
10/7/2009
$55,000,000
Adimab
10/1/2009
Unknown
Cadent Dental
9/30/2009
$15,000,000
valenTx
9/8/2009
$22,000,000
OphthoTech
6/30/2009
$4,720,000
Ocular Therapeutix
6/19/2009
$15,000,000
Sadra Medical
5/7/2009
$30,000,000
Link Medicine
3/31/2009
$6,560,000
Accelecare Wound Centers
3/31/2009
$1,580,000
TransEnterix
3/31/2009
$3,430,000
Archemix
3/31/2009
$6,500,000
Sutro Biopharma
3/30/2009
$15,000,000
LenSx Lasers
3/29/2009
$22,000,000
NKT Therapeutics
3/16/2009
$8,000,000
Ikano Therapeutics
3/2/2009
$9,000,000
ReShape Medical
2/3/2009
$20,000,000
Logical Therapeutics
12/31/2008
$6,000,000
CHF Solutions
12/31/2008
$5,200,000
Accelecare Wound Centers
12/31/2008
$100,000
Itero Biopharmaceuticals
12/31/2008
$12,750,000
Adimab
11/20/2008
Unknown
Link Medicine
9/30/2008
$40,000,000
CR
9/30/2008
$14,800,000
EBR Systems
7/29/2008
$35,000,000
AlloCure
7/2/2008
$14,500,000
Ikano Therapeutics
6/30/2008
$9,000,000
Socios Mayores en Salud
6/30/2008
$12,000,000
OphthoTech
6/30/2008
$24,470,400
Itero Biopharmaceuticals
6/11/2008
$21,000,000
Entellus Medical
6/9/2008
$15,000,000
MindFrame
3/31/2008
$5,955,000
Halscion
3/31/2008
$4,500,000
EUSA Pharma
3/11/2008
$50,000,000
Ocular Therapeutix
3/7/2008
$6,000,000
TransEnterix
12/31/2007
$21,000,000
Itero Biopharmaceuticals
12/31/2007
$1,018,000
CoreLab Partners
12/31/2007
$1,000,000
Fundamental Applied Biology
12/10/2007
$21,000,000
OsteoLign
9/10/2007
$10,000,000
ReShape Medical
9/4/2007
$3,000,000
Entellus Medical
8/13/2007
$9,000,000
Adimab
7/20/2007
$6,000,000
CardioMind
7/3/2007
$33,000,000
Archemix
6/30/2007
$29,844,000
Ikano Therapeutics
6/30/2007
$4,200,000
CRI Lifetree
6/30/2007
$15,700,000
Accelecare Wound Centers
6/30/2007
$10,292,000
The Innovation Factory
6/27/2007
$7,000,000
Logical Therapeutics
6/13/2007
$30,000,000
Quick Study Radiology
3/31/2007
$3,300,000
PINT
3/26/2007
$18,000,000
Lux Biosciences
12/31/2006
$18,000,000
Socios Mayores en Salud
12/31/2006
$1,422,000
NeoVista
12/8/2006
$41,000,000
Neurotech Pharmaceuticals
11/16/2006
$35,000,000
OsteoLign
9/30/2006
$900,000
Ikano Therapeutics
8/15/2006
$39,100,000
ESBATech AG
8/2/2006
$41,000,000
Lux Biosciences
7/19/2006
$13,000,000
US Renal Care
7/10/2006
$36,000,000
ReShape Medical
6/30/2006
$4,500,000
Achillion Pharmaceuticals
6/30/2006
$13,750,400
Lux Biosciences
5/25/2006
$36,000,000
CardioFocus
4/24/2006
$21,500,000
Achillion Pharmaceuticals
3/31/2006
$4,800,200
Alba Therapeutics
3/31/2006
$23,000,000
NeoVista
3/31/2006
$6,000,000
Avera Pharmaceuticals
3/31/2006
$17,999,700
Insulet
2/16/2006
$50,000,000
Socios Mayores en Salud
1/13/2006
$9,400,000
Alinea Pharmaceuticals
10/20/2005
$45,000,000
GlycoFi
10/10/2005
$11,000,000
ReShape Medical
9/30/2005
$500,000
Alba Therapeutics
8/22/2005
$30,000,000
Mpex Pharmaceuticals
8/9/2005
$32,000,000
AcuFocus
6/30/2005
$27,500,000
US Renal Care
3/31/2005
$12,500,000
Avera Pharmaceuticals
3/31/2005
$18,000,200
Quick Study Radiology
3/31/2005
$2,030,000
MDeverywhere
3/31/2005
$629,900
Confluent Surgical
3/30/2005
$23,000,000
Alantos Pharmaceuticals Holding
3/10/2005
$20,000,000
Cadent Dental
3/5/2005
$25,000,000
CHF Solutions
1/19/2005
$22,900,000
Solexa
9/27/2004
$14,400,000
PowderJect Pharmaceuticals PLC
5/17/2004
$34,500,000
Archemix
4/14/2004
$50,000,000
GlycoFi
12/10/2003
$10,000,000
Cellzome AG
3/18/2003
$38,330,400

 

Investor Contacts

Title
Name
Email & Social
Managing Partner
Houman Ashrafian
  Houman Ashrafian LinkedIn Profile  Houman Ashrafian Twitter Account  Houman Ashrafian News  Houman Ashrafian on Facebook
Managing Partner
Michael Balmuth
  Michael Balmuth LinkedIn Profile  Michael Balmuth Twitter Account  Michael Balmuth News  Michael Balmuth on Facebook
Managing Partner
Kate Bingham
  Kate Bingham LinkedIn Profile  Kate Bingham Twitter Account  Kate Bingham News  Kate Bingham on Facebook
Managing Partner
Thomas Flynn
  Thomas Flynn LinkedIn Profile  Thomas Flynn Twitter Account  Thomas Flynn News  Thomas Flynn on Facebook
Managing Partner
Eugene Hill
  Eugene Hill LinkedIn Profile  Eugene Hill Twitter Account  Eugene Hill News  Eugene Hill on Facebook
Managing Partner
Paul LaViolette
  Paul LaViolette LinkedIn Profile  Paul LaViolette Twitter Account  Paul LaViolette News  Paul LaViolette on Facebook
Partner
Greg Madden
  Greg Madden LinkedIn Profile  Greg Madden Twitter Account  Greg Madden News  Greg Madden on Facebook
Managing Partner
Michael Ross
  Michael Ross LinkedIn Profile  Michael Ross Twitter Account  Michael Ross News  Michael Ross on Facebook

 

Funds

Our database includes the following fund closing(s) for SV Health Investors. If we are missing funds, please contact us.

Fund Description
Vintage Date
Fund Amount
SV Life Sciences Fund VI
5/27/2016
$273,500,000
SV Life Sciences Fund V
6/29/2010
$523,000,000
SV Life Sciences Fund IV
2/20/2007
$572,000,000

 

Portfolio Companies

SV Health Investors has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Tech Company
Accelecare Wound Centers
Achillion Pharmaceuticals
AcuFocus
Adimab
AeroCare
Aiko Biotechnology
Alantos Pharmaceuticals Holding
Alba Therapeutics
Aligned TeleHealth
Alinea Pharmaceuticals
AlloCure
Altura Medical
AqueSys
Archemix
Arsanis
Avera Pharmaceuticals
Avitide
Avrobio
Bardy Diagnostics
BioAge Labs
Brixton Biosciences
Cadent Dental
CardioFocus
CardioKinetix
CardioMind
Catabasis Pharmaceuticals
Catamaran Bio
Cellzome AG
CHF Solutions
Cibiem
Clarify Medical
Confluent Surgical
CoreLab Partners
Coridea
CR
CRI Lifetree
CSA Medical
Cyterix Pharmaceuticals
Deciphera Pharmaceuticals
Direct Flow Medical
EBR Systems
EBT Medial
Enara Bio
Endotronix
Entellus Medical
ESBATech AG
EUSA Pharma
Evidation Health
EyeBio
EyeBiotech
Fundamental Applied Biology
GlycoFi
Good Start Genetics
Halscion
Health Essentials
Health Payment Systems
Healthify
Ikano Therapeutics
Imagen Biotech
Insulet
Itero Biopharmaceuticals
Jet Health
Juvaris BioTherapeutics
KalVista Pharmaceuticals
Kesios Therapeutics
LenSx Lasers
Link Medicine
Logical Therapeutics
Lux Biosciences
MDeverywhere
MIACH Orthopaedics
MindFrame
Montara Therapeutics
Mpex Pharmaceuticals
Nanopath
NeoVista
Neurotech Pharmaceuticals
Nimbus Therapeutics
NKT Therapeutics
Ocular Therapeutix
OphthoTech
OsteoLign
PanOptica
PINT
Pionyr Immunotherapeutics
PowderJect Pharmaceuticals PLC
Precision Immune
Pulmocide
Quell Therapeutics
Quick Study Radiology
Rempex Pharmaceuticals
ReShape Medical
Rheostat Therapeutics
Ria Health
Ribometrix
Sadra Medical
Sitryx Therapeutics
Socios Mayores en Salud
Solexa
SpectraWAVE
Spinal Kinetics
Spineology
SUN Behavioral Health
Sutro Biopharma
The Innovation Factory
Therini Bio
Thesan Pharmaceuticals
TransEnterix
TRexBio
US Renal Care
valenTx
Xilio Therapeutics
Ximedica

 

 

 

 

Browse more venture capital investors:

SV Capital | SV Investment

 

Share this article

 

About Our Venture Capital Investors Database

This VC firm profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.